Literature DB >> 16286470

Cooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signaling.

Yun-Wei Lin1, Jia-Ling Yang.   

Abstract

The dual-specificity MAPK phosphatase MKP-1/CL100/DUSP1 is an inducible nuclear protein controlled by p44/42 MAPK (ERK1/2) in a negative feedback mechanism to inhibit kinase activity. Here, we report on the molecular basis for a novel positive feedback mechanism to sustain ERK activation by triggering MKP-1 proteolysis. Active ERK2 docking to the DEF motif (FXFP, residues 339-342) of N-terminally truncated MKP-1 in vitro initiated phosphorylation at the Ser(296)/Ser(323) domain, which was not affected by substituting Ala for Ser at Ser(359)/Ser(364). The DEF and Ser(296)/Ser(323) sites were essential for ubiquitin-mediated MKP-1 proteolysis stimulated by MKK1-ERK signaling in H293 cells, whereas the N-terminal domain and Ser(359)/Ser(364) sites were dispensable. ERK activation by serum increased the endogenous level of ubiquitinated phospho-Ser(296) MKP-1 and the degradation of MKP-1. Intriguingly, active ERK-promoted phospho-Ser(296) MKP-1 bound to SCF(Skp2) ubiquitin ligase in vivo and in vitro. Forced expression of Skp2 enhanced MKP-1 polyubiquitination and proteolysis upon ERK activation, whereas depletion of endogenous Skp2 suppressed such events. The kinetics of ERK signaling stimulated by serum correlated with the endogenous MKP-1 degradation rate in a Skp2-dependent manner. Thus, MKP-1 proteolysis can be achieved via ERK and SCF(Skp2) cooperation, thereby sustaining ERK activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16286470     DOI: 10.1074/jbc.M508720200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Prolonged proinflammatory cytokine production in monocytes modulated by interleukin 10 after influenza vaccination in older adults.

Authors:  Subhasis Mohanty; Samit R Joshi; Ikuyo Ueda; Jean Wilson; Tamara P Blevins; Barbara Siconolfi; Hailong Meng; Lesley Devine; Khadir Raddassi; Sui Tsang; Robert B Belshe; David A Hafler; Susan M Kaech; Steven H Kleinstein; Mark Trentalange; Heather G Allore; Albert C Shaw
Journal:  J Infect Dis       Date:  2014-11-02       Impact factor: 5.226

2.  Heparin treatment of vascular smooth muscle cells results in the synthesis of the dual-specificity phosphatase MKP-1.

Authors:  Cheryl Isleib Blaukovitch; Raymond Pugh; Albert C Gilotti; Daniela Kanyi; Linda J Lowe-Krentz
Journal:  J Cell Biochem       Date:  2010-05-15       Impact factor: 4.429

Review 3.  Analysis of mitogen-activated protein kinase activation and interactions with regulators and substrates.

Authors:  Lee Bardwell; Kandarp Shah
Journal:  Methods       Date:  2006-11       Impact factor: 3.608

4.  Substrate discrimination among mitogen-activated protein kinases through distinct docking sequence motifs.

Authors:  Douglas L Sheridan; Yong Kong; Sirlester A Parker; Kevin N Dalby; Benjamin E Turk
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

Review 5.  Crosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatases.

Authors:  Ilse M E Beck; Wim Vanden Berghe; Linda Vermeulen; Keith R Yamamoto; Guy Haegeman; Karolien De Bosscher
Journal:  Endocr Rev       Date:  2009-11-04       Impact factor: 19.871

6.  Ubiquitin-activating enzyme E1 inhibitor PYR41 attenuates angiotensin II-induced activation of dendritic cells via the IκBa/NF-κB and MKP1/ERK/STAT1 pathways.

Authors:  Chen Chen; Yan Meng; Lei Wang; Hong-Xia Wang; Cui Tian; Guo-Dong Pang; Hui-Hua Li; Jie Du
Journal:  Immunology       Date:  2014-06       Impact factor: 7.397

7.  Cocaine- and amphetamine-regulated transcript accelerates termination of follicle-stimulating hormone-induced extracellularly regulated kinase 1/2 and Akt activation by regulating the expression and degradation of specific mitogen-activated protein kinase phosphatases in bovine granulosa cells.

Authors:  Aritro Sen; Lihua Lv; Nora Bello; James J Ireland; George W Smith
Journal:  Mol Endocrinol       Date:  2008-09-25

8.  New specific molecular targets for radio-chemotherapy of rectal cancer.

Authors:  Kristin Snipstad; Christopher G Fenton; Jørn Kjaeve; Guanglin Cui; Endre Anderssen; Ruth H Paulssen
Journal:  Mol Oncol       Date:  2009-11-25       Impact factor: 6.603

9.  TLR4 signaling in effector CD4+ T cells regulates TCR activation and experimental colitis in mice.

Authors:  José M González-Navajas; Sean Fine; Jason Law; Sandip K Datta; Kim P Nguyen; Mandy Yu; Maripat Corr; Kyoko Katakura; Lars Eckman; Jongdae Lee; Eyal Raz
Journal:  J Clin Invest       Date:  2010-01-04       Impact factor: 14.808

10.  Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patients.

Authors:  C Montagut; M Iglesias; M Arumi; B Bellosillo; M Gallen; A Martinez-Fernandez; L Martinez-Aviles; I Cañadas; A Dalmases; E Moragon; L Lema; S Serrano; A Rovira; F Rojo; J Bellmunt; J Albanell
Journal:  Br J Cancer       Date:  2010-03-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.